LYNGBY, DENMARK — A driver’s risk of being severely injured in an accident is highest after having either consumed alcohol alone, resulting in a blood/alcohol level above .08, or in combination with other psychoactive substances, according to the findings of a population-based case-controlled study published online in the journal Accident Analysis and Prevention. Danish researchers assessed the overall […]
Cannabis Associated With Less Risk of Traffic Accident Compared to Alcohol, Prescription Drugs was written by Paul Armentano and appears in full on The Daily Chronic. Want to stay up to date on cannabis news worldwide? Visit The Daily Chronic - The Voice of the Reform Generation. . . . . READ MORE
PHILADELPHIA, PA — Cannabis consumption is associated with mitigated symptoms of opiate withdrawal in subjects undergoing methadone maintenance treatment, according to the findings of a new study published online in The American Journal on Addictions.
Investigators at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia assessed the use of cannabis in 91 opiate-dependent subjects undergoing methadone maintenance treatment. Researchers found that subjects seeking methadone treatment who acknowledged a history of cannabis use reported “significantly less daily expenditure on acquisition of opiates.”
Authors additionally reported that subjects’ use of cannabis during treatment was associated with less severe symptoms of withdrawal on the clinical opiate withdrawal scale (COWS), an index designed to serve as an objective measure of opiate withdrawal. “[I]ncreased cannabis use was found to be associated with lower severity of [opiate] withdrawal in a subset of the sample with available chart data,” authors wrote. “These results suggested a potential role for cannabis in the reduction of withdrawal severity during methadone induction.”
They concluded, “The present findings may point to novel interventions to be employed during treatment for opiate dependence that specifically target cannabinoid–opioid system interactions.”
A 200. . . . . READ MORE